Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taebum Lee

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
NPJ Precision Oncology|December 3, 2024
A universal immunohistochemistry analyzer for generalizing AI-driven assessment of immunohistochemistry across immunostains and cancer typesBiagio Brattoli, Mohammad Mostafavi, Taebum Lee, et al.
Head & Neck|January 7, 2020
Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature reviewTaebum Lee, Junhun Cho, Chung-Hwan Baek, et al.
Breast Cancer Research : BCR|February 23, 2024
Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 casesMinsun Jung, Seung Geun Song, Soo Ick Cho, et al.
Cancer|October 18, 2024
Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-09)Miso Kim, Yu Jung Kim, Koung Jin Suh, et al.
Cancer Research Communications|November 10, 2025
Deep Learning Predicts EGFR Mutation Status from Histology Images in Non-Small Cell Lung CancerJongchan Park, Sangwon Shin, Woochan Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2024
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as a Potential Biomarker for Immune Checkpoint Inhibitors in Patients with Biliary Tract CancerYeong Hak Bang, Choong-Kun Lee, Kyunghye Bang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 13, 2025
Pathologist-Artificial Intelligence Concordance in HER2 Interpretation for Advanced Biliary Tract Cancer: Intraobserver, Interobserver, and Human-Artificial Intelligence VariabilityHyunchul Kim, Jinhyung Heo, Soo Ick Cho, et al.
Translational Lung Cancer Research|July 18, 2020
Artificial intelligence and lung cancer treatment decision: agreement with recommendation of multidisciplinary tumor boardMin-Seok Kim, Ha-Young Park, Bo-Gun Kho, et al.
Journal for Immunotherapy of Cancer|February 14, 2024
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer typesJeanne Shen, Yoon-La Choi, Taebum Lee, et al.
Genome Biology|November 28, 2019
Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancersJason K Sa, Jae Ryoung Hwang, Young-Jae Cho, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
NPJ Precision Oncology|December 3, 2024
A universal immunohistochemistry analyzer for generalizing AI-driven assessment of immunohistochemistry across immunostains and cancer typesBiagio Brattoli, Mohammad Mostafavi, Taebum Lee, et al.
Head & Neck|January 7, 2020
Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature reviewTaebum Lee, Junhun Cho, Chung-Hwan Baek, et al.
Breast Cancer Research : BCR|February 23, 2024
Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 casesMinsun Jung, Seung Geun Song, Soo Ick Cho, et al.
Cancer|October 18, 2024
Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-09)Miso Kim, Yu Jung Kim, Koung Jin Suh, et al.
Cancer Research Communications|November 10, 2025
Deep Learning Predicts EGFR Mutation Status from Histology Images in Non-Small Cell Lung CancerJongchan Park, Sangwon Shin, Woochan Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2024
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as a Potential Biomarker for Immune Checkpoint Inhibitors in Patients with Biliary Tract CancerYeong Hak Bang, Choong-Kun Lee, Kyunghye Bang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 13, 2025
Pathologist-Artificial Intelligence Concordance in HER2 Interpretation for Advanced Biliary Tract Cancer: Intraobserver, Interobserver, and Human-Artificial Intelligence VariabilityHyunchul Kim, Jinhyung Heo, Soo Ick Cho, et al.
Translational Lung Cancer Research|July 18, 2020
Artificial intelligence and lung cancer treatment decision: agreement with recommendation of multidisciplinary tumor boardMin-Seok Kim, Ha-Young Park, Bo-Gun Kho, et al.
Journal for Immunotherapy of Cancer|February 14, 2024
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer typesJeanne Shen, Yoon-La Choi, Taebum Lee, et al.
Genome Biology|November 28, 2019
Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancersJason K Sa, Jae Ryoung Hwang, Young-Jae Cho, et al.
Pageof 4